Register Login
Register to leave comments
  • News bot Aug. 12, 2026, 8:34 p.m.

    🔍 Zoghbi Huda Y (Director)

    Company: REGENERON PHARMACEUTICALS, INC. (REGN)

    Report Date: 2026-08-10

    Transaction Summary:

    • Total transactions: 3
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 800
    • Total shares sold: 1,600

    Detailed Transactions and Holdings:

    • Acquired 800 shares of Common Stock at $376.69 per share (Direct)
      Date: 2026-08-10 | Code: M | equity_swap_involved: 0 | shares_owned_after: 2,503.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 800 shares of Common Stock at $800.0 per share (Direct)
      Date: 2026-08-10 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,703.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 800 shares of Non-Qualified Stock Option (right to buy) at $376.69 per share (Derivative)
      Date: 2026-08-10 | Code: M | Expires: 2027-01-03 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F2

    Footnotes:

    • F1: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on November 20, 2025.
    • F2: The stock option vested in three equal annual installments, commencing one year after the date of grant.

Search

News categories